Mouse xenograft models vs GEM models for human cancer therapeutics

被引：290

作者：

Richmond, Ann ^{[1
,2
]}

Su, Yingjun ^{[1
,2
]}

机构：

[1] Vanderbilt Univ, Dept Canc Biol, Sch Med, Nashville, TN 37235 USA

[2] VA Med Ctr, Nashville, TN USA

来源：

DISEASE MODELS & MECHANISMS | 2008年 / 1卷 / 2-3期

关键词：

D O I：

10.1242/dmm.000976

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：78 / 82

页数：5

共 18 条

[1]

Baselga J, 1998, CANCER RES, V58, P2825

[2] Establishing humanized mice using stem cells: maximizing the potential [J].

Bernard, D. ;

Peakman, M. ;

Hayday, A. C. .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 152 (03) :406-414

[3] Regional effects of an antivascular endothelial growth factor receptor monoclonal antibody on receptor phosphorylation and apoptosis in human 253J B-V bladder cancer xenografts [J].

Davis, DW ;

Inoue, K ;

Dinney, CPN ;

Hicklin, DJ ;

Abbruzzese, JL ;

McConkey, DJ .

CANCER RESEARCH, 2004, 64 (13) :4601-4610

[4] Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].

Hurwitz, H ;

Fehrenbacher, L ;

Novotny, W ;

Cartwright, T ;

Hainsworth, J ;

Heim, W ;

Berlin, J ;

Baron, A ;

Griffing, S ;

Holmgren, E ;

Ferrara, N ;

Fyfe, G ;

Rogers, B ;

Ross, R ;

Kabbinavar, F .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342

[5] Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials [J].

Johnson, JI ;

Decker, S ;

Zaharevitz, D ;

Rubinstein, LV ;

Venditti, J ;

Schepartz, S ;

Kalyandrug, S ;

Christian, M ;

Arbuck, S ;

Hollingshead, M ;

Sausville, EA .

BRITISH JOURNAL OF CANCER, 2001, 84 (10) :1424-1431

[6] Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development [J].

Kelland, LR .

EUROPEAN JOURNAL OF CANCER, 2004, 40 (06) :827-836

[7]

Kerbel RS, 2003, CANCER BIOL THER, V2, pS134

[8] Orthotopic models are necessary to predict therapy of transplantable tumors in mice [J].

Killion, JJ ;

Radinsky, R ;

Fidler, IJ .

CANCER AND METASTASIS REVIEWS, 1998, 17 (03) :279-284

[9]

LeBlanc R, 2002, CANCER RES, V62, P4996

[10] Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma:: results of a multicenter phase 1/2 study [J].

Mateos, Maria-Victoria ;

Hernandez, Jose-M. ;

Hernandez, Miguel-T ;

Gutierrez, Norma-C. ;

Palomera, Luis ;

Fuertes, Marta ;

Diaz-Mediavilla, Joaquin ;

Lahuerta, Juan-J. ;

de la Rubia, Javier ;

Terol, Maria-Jose ;

Sureda, Ana ;

Bargay, Joan ;

Ribas, Paz ;

de Arriba, Felipe ;

Alegre, Adrian ;

Oriol, Albert ;

Carrera, Dolores ;

Garcia-Larana, Jos ;

Garcia-Sanz, Ramon ;

Blade, Joan ;

Prosper, Felipe ;

Mateo, Gemma ;

Esseltine, Dixie-Lee ;

de Velde, Helgi van ;

San Miguel, Jesus-F. .

BLOOD, 2006, 108 (07) :2165-2172

← 1 2 →